95 results
8-K
KA
Kineta Inc
16 Aug 23
Other Events
4:00pm
written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance … 30 consecutive business days.
On August 15, 2023, the Company received written notice from the Listing Qualifications Department of Nasdaq notifying
8-K
EX-99.1
KA
Kineta Inc
2 Dec 19
Other Events
7:02am
the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance
8-K
KA
Kineta Inc
2 Dec 19
Other Events
7:02am
announcing that it received a letter dated November 27, 2019 from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying
8-K
KA
Kineta Inc
3 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:31am
On June 27, 2023, Kineta, Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock
8-K
vynxf z7e2xbmr22kd
30 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
cd3 9n4caim
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.1
xdi5copbbzn12rk3r
11 May 23
Kineta Reports First Quarter 2023 Financial Results and Provides Corporate Update
5:20pm
8-K
EX-99.1
zz8bbgi lzb999
22 Jan 20
Proteostasis Therapeutics Announces Keystone Symposia Presentation of
7:00am
8-K
EX-10.1
kap9od3 74l6oaw9t
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
6ui2lv8my6ez2
17 Oct 18
Proteostasis Therapeutics Announces Positive Preliminary Results from
4:30pm
S-4
EX-10.32
au1sd8jlaal003 d7gwk
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
S-4
EX-10.33
krcr 6dra7
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm